NYMX - Nymox Pharmaceutical up 37% as it assures shareholders company is well funded
- Nymox Pharmaceutical has informed its shareholders that the company is well funded and its business plans are "on track."
- Shares are up 37% in morning trading.
- On Thursday, Nymox ( NASDAQ: NYMX ) received a non-compliance letter from Nasdaq .
- CEO Paul Averback said that the company will provide updates on its projects throughout the year.
For further details see:
Nymox Pharmaceutical up 37% as it assures shareholders company is well funded